Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.85 |
| ▸ | TSHR | P16473 | 6/20 | 0.85 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.85 |
| ▸ | HPGD | P15428 | 4/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.85 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.85 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.85 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | FYN | P06241 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | AHR | P35869 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrene SCHEMBL27737703 | 0.96 | ALDH1A1 (0.79) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL29429699 | 0.92 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| SCHEMBL31298365 | 0.92 | ALDH1A1 (0.83) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL1650929 | 0.92 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL223412 | 0.92 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| SCHEMBL1704742 | 0.92 | ALDH1A1 (0.83) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL1332849 | 0.92 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL9130 | 0.92 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL23319293 | 0.88 | ALDH1A1 (0.92) | ALDH1A1HSD17B10TSHRCYP1A2HPGD | |
| Pyrene SCHEMBL1275551 | 0.88 | ALDH1A1 (0.92) | ALDH1A1HSD17B10TSHRCYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110204691-B | Nanobelt based on fused ring graphene and preparation method | 南京邮电大学 | 2021-11-12 | — | — | CN | claimed |
| CN-110204691-A | One kind being based on condensed ring graphene nanobelt and preparation method | 南京邮电大学 | 2019-09-06 | — | — | CN | claimed |
| US-20240077837-A1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | JOHNSON & JOHNSON VISION CARE (US) | 2024-03-07 | — | — | US | disclosed |
| US-11853013-B2 | Systems and methods for indicating the time elapsed since the occurrence of a triggering event | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| EP-4165465-A1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | Johnson & Johnson Vision Care, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| WO-2021255536-A1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2021-12-23 | — | — | WO | disclosed |
| US-20210389731-A1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | JOHNSON & JOHNSON VISION CARE, INC. | 2021-12-16 | — | — | US | disclosed |
| CN-110204691-B | Nanobelt based on fused ring graphene and preparation method | 南京邮电大学 | 2021-11-12 | — | — | CN | disclosed |
| EP-3728513-A1 | POLYMERIZATION COMPOSITION FOR PRODUCING A SCINTILLATING HYBRID MATERIAL AND ASSOCIATED KITS | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2020-10-28 | — | — | EP | disclosed |
| EP-3728514-A1 | SCINTILLATING HYBRID MATERIAL, ASSOCIATED PART, ASSOCIATED DEVICE AND ASSOCIATED APPARATUS, METHODS FOR PRODUCING OR MEASURING SAME | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2020-10-28 | — | — | EP | disclosed |
| CN-110204691-A | One kind being based on condensed ring graphene nanobelt and preparation method | 南京邮电大学 | 2019-09-06 | — | — | CN | disclosed |
| CN-106282057-B | Bacterial strain capable of degrading polycyclic aromatic hydrocarbon and application thereof | 台州职业技术学院 | 2019-05-28 | — | — | CN | disclosed |
| CN-106282057-A | Bacterial strain capable of degrading polycyclic aromatic hydrocarbon and application thereof | 台州职业技术学院 | 2017-01-04 | — | — | CN | disclosed |
| CN-105658606-A | Anthracene compound; light-emitting-layer material; and organic electroluminescent element, display device, and illumination device using same | 捷恩智株式会社 | 2016-06-08 | — | — | CN | disclosed |
| US-9010318-B2 | Extended-range heat transfer fluid using variable composition | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-04-21 | — | — | US | disclosed |
| US-20110146959-A1 | EXTENDED-RANGE HEAT TRANSFER FLUID USING VARIABLE COMPOSITION | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2011-06-23 | — | — | US | disclosed |
| WO-2009056344-A1 | CORE-SHELL MACROMOLECULES FOR SPECIFIC CELL NUCLEUS OR/AND CELL MATRIX STAINING | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2009-05-07 | — | — | WO | disclosed |
| EP-1440105-B1 | PARTICULATE HYDROPHOBIC POLYMER, PRODUCTION PROCESS THEREFOR AND COLUMN FOR REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | SHOWA DENKO KK (JP) | 2006-12-27 | — | — | EP | disclosed |
| CN-1046178-A | A kind of oil-saving agent | ZHAN XIAOLING (CN) | 1990-10-17 | — | — | CN | disclosed |
| US-4465833-A | ALKYNYLATION HALOGENATED BENZENE COMPOUND IN PRESENCE OF METAL CATALYST | HUGHES AIRCRAFT COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11853013-B2 | Systems and methods for indicating the time elapsed since the occurrence of a triggering event | MTREX, CD63, CASP6 | ALDH1A1 4471/4885HSD17B10 4323/4885TSHR 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.